2023 On-Demand Webinar: CAR-T Cells and T-Cell Receptor Cells in Solid Tumors
Overview
Chimeric antigen receptor (CAR)-T and T-cell receptor (TCR) cell therapies have emerged as promising approaches for solid tumor treatment, showcasing encouraging potential in recent clinical studies12. This on-demand webinar will provide a comprehensive overview of the current landscape, focusing on the latest clinical experiences with CAR-T cells in solid tumors and the unique manufacturing considerations associated with these therapies. The presenters will examine the critical need for establishing robust safety and efficacy quality benchmarks for both CAR-T cells and TCRs, addressing the challenges that have limited their efficacy in solid tumors compared to hematological malignancies. Participants will gain valuable insights into the similarities and differences between CAR-T and TCR platforms, the specific manufacturing hurdles encountered in developing these therapies for solid tumors, and the role of FACT in establishing industry-wide standards. This session promises to be an essential resource for professionals seeking to advance their understanding of these cutting-edge immunotherapies and their potential impact on solid tumor treatment strategies.
-
Register
- Applicant - $100
- Auditor - Free!
- Committee Member - $100
- Consultant - Free!
- FACT Staff - Free!
- Inspector - Free!
- Inspector Trainee - Free!
- Non-member - $100
- Industry Representative - $200
- Fellow - $50
Already registered?
Log in to access.
Key:
Complete
Next
Failed
Available
Locked